Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Gene Transfer Therapy for Gastrointestinal Cancer
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial tests a new cancer treatment where a patient's white blood cells are modified in a lab to target specific cancer cells. It is aimed at adults aged 18-72 with advanced cancers that have a specific mutation (KRAS G12V) and have not responded to other treatments. The modified cells are reintroduced into the patient to seek out and destroy the cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service